The company could secure a higher price for the new test than for its older, narrower product, Wall Street analysts said.

To address remote hiring challenges, psychometric tests offer reliable, data-driven insights into candidates' personalities and work styles. This approach fosters better hiring decisions, enhances ...

GUARDANT HEALTH LAUNCHES GUARDANT360 TISSUE, FIRST TISSUE MOLECULAR PROFILING TEST WITH COMPREHENSIVE MULTIOMIC ANALYSIS TO PROVIDE A MORE COMPLETE VIEW OF CANCER Powered by Guardant Infinity smart ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Guardant Health Inc.’s GH Guardant360 Liquid CDx test, ...

BIOTIA-DX Resistance is now available for clinical use through the New York State CLEP-approved BIOTIA-ID Urine Test, ...

Only blood test approved by FDA as companion diagnostic for ORSERDU™ (elacestrant), Guardant360 CDx gains coverage by Aetna and Humana to identify eligible patients with advanced breast cancer prior ...

Genomic profiling can help personalize cancer care, but patients may not be offered these tests due to a burdensome ...

Singapore's leading national tertiary cancer centre, National Cancer Centre Singapore, has announced a new S$6 million ($4.7 million) collaboration to develop an AI-powered cancer test that uses ...

Grafana Labs has launched Pyroscope 2.0, a rearchitected open-source continuous profiling database. This version improves ...

Powered by Guardant Infinity smart liquid biopsy platform, advanced multiomic test evaluates genomic, epigenomic and RNA-based molecular data First tissue comprehensive genomic profiling test to offer ...